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Abstract. This report summarises the outcome of 90
combined kidney/pancreatic grafts performed in
Europe in 1986. Data for the combined kidney/pancreas
grafts were obtained by a special questionnaire. The
one-year patient and kidney graft survival is compared
to the results of a group of 389 patients with diabetic
nephropathy on the EDTA Registry data file who
received kidney grafts alone. The recipients of com-
bined kidney-pancreas grafts were younger, whereas a
greater proportion of males received kidney graft alone.
Patient survival at one year after transplantation was
similar: 89% in recipients of combined transplants
compared to 90% in recipients of kidney grafts alone.
Kidney graft survival was 78% at one year for recipients
of combined grafts versus 76%. It is concluded that
pancreas transplantation has little effect on the fate of
concomitant kidney grafts. The procedure should - in
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experienced hands and in selected patients - be almost
as safe as kidney grafting alone.
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Introduction
Ever since the advent of combined pancreas and kidney
grafting in patients with diabetic nephropathy, the
advantages and hazards of pancreatic grafting have
been a matter of controversy. The impact of pancreatic
grafting on patient survival and on the fate of the
simultaneously transplanted kidney graft have been
discussed extensively [1-4]. In 1984 McMaster and co-
workers [4] suggested that combined grafting was not
hazardous either to the patient or to the kidney graft.
However, this conclusion was based on a small number
of cases. Data presented from the International Pan-
creas Registry in Minnesota [5] showed reasonably good
kidney graft survival, even though an adequate control
group of patients receiving kidney grafts without pan-
creatic grafts was lacking.
To analyse further the question of patient and graft
survival, the EDTA Registry investigated the results of
90 combined kidney/pancreas grafts performed in 1986
in Europe.
Material and Methods
A total of 122 combined kidney/pancreas transplants
performed in 1986 in Europe were brought to the
attention of the EDTA Registry through the 1986 centre
questionnaire supplemented by information from
National Keymen and other sources. A total of 96
special questionnaires were sent in early 1988 to all
centres that reported having performed two or more
combined grafts in 1986. Information was sought on
individual graft recipients concerning sex, date of birth,
date of transplantation, date of failure of pancreas/ or
kidney graft, date of death, or whether the patient was
alive at the end of 1987. Of the 96 questionnaires, 90
(93.8%) were completed and returned.
A control group was selected from the EDTA patient
file. This control group consisted of all (389) reported
kidney grafts in patients with diabetic nephropathy
performed in 1986 in the following countries: Belgium,
Denmark, Federal Republic of Germany, Finland,
France, Switzerland, and the United Kingdom. Care
was taken to exclude patients from these countries who
had been subjected to combined kidney and pancreas
grafting. Actuarial patient and graft survival rates were
computed when the complete patient data up to the end
of 1987 were available.
In all instances, standard actuarial methodology was
used. Patient death with a functioning graft was counted
as graft failure in the calculations.
Results
Table 1 depicts the distribution of the combined kidney/
pancreas grafts in 1986 by country. There was a relative
predominance of combined grafts in Sweden and
Norway. The remainder of the grafts were performed in
Central Europe and relatively few in France, the United
Kindgom, and Italy. Because of the uneven distribution
of the combined grafts if was felt that a control group of
recipients of kidney grafts alone should be restricted to a
similar geographical area. However, Sweden and
Norway were omitted as it was felt that the remainder of
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the diabetic graft recipients in these Scandinavian
countries who had not received combined grafts might
introduce a bias through a selection of higher-risk
patients.
Table 1. Number of combined kidney/pancreatic transplants per-
formed in 1986 according to country. In 1986, 26 centres reported
performing 122 combined kidney/pancreatic transplants
Country
Austria
Belgium
Czechoslovakia
France
FRG
GDR
Italy
Netherlands
Norway
Spain
Sweden
Switzerland
UK
Total performed in 1986
Transplants (n)
5
3
4
13
25
2
3
10
10
4
31
4
8
122
Age and Sex Distribution
Figure 1 shows the age and sex distribution of patients
who underwent combined kidney and pancreas grafting
(Fig. la) and those who received a kidney graft alone
(Fig. lb). In general, recipients of combined grafts
tended to be younger. The median age at transplant-
ation was 36 years for patients with combined grafts
and, at 39 years, was slightly greater for recipients of
kidney grafts alone (non-significant). Only three
patients who received combined grafts were between 50
and 60 years old, whereas 16% of the kidney recipients
were aged between 50 and 60 years, and 3% were over
60 years old. The sex distribution of 53% males versus
47% females for recipients of combined grafts differed
strikingly from the patients receiving kidneys alone, of
whom 65% were male and 35% female.
Patient and Graft Survival
The patient survival is shown in Figs 2a and 2b. It was
almost equal in the two groups, with 89% survival at 1
year for recipients of combined grafts compared to 90%
for recipients of kidney graft alone. The kidney graft
survival also differed little, with a 1-year survival of 78%
with combined grafting versus 76% in patients without
pancreatic grafts. The pancreas graft survival shown in
Fig. 2a was 65% at 1 year.
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Fig. la. Age distribution at combined kidney and pancreas transplan- Fig. 2a. Diabetic ESRF: Survival after combined kidney and pancreas
tation for diabetic ESRF, 1986. transplantation, 1986.
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Fig. lb. Age distribution at kidney transplantation for diabetic ESRF, Fig. 2b. Diabetic ESRF: Survival after kidney transplantation 1986.
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Discussion
The present report demonstrates that both patient and
kidney graft survival are comparable in patients under-
going either kidney transplantation alone or combined
with pancreas transplantation. The outcome of kidney
transplantation with concomitant pancreas grafting was
compared to the results of kidney grafting in patients
with diabetic nephropathy who underwent transplan-
tation during the same year and who were from a similar
geographical area. Although this comparison cannot
match the criteria of a randomised study, it nevertheless
provides a useful comparison of the two surgical
approaches. Details of sex and age distribution suggest
that the two groups are not entirely comparable. For
unknown reasons, females appeared to be accepted for
combined transplantation at the slightly higher pro-
portion of 47% as compared to the 42% female preva-
lence with diabetic nephropathy (44% for type I dia-
betes mellitus) among patients accepted for renal
replacement therapy in 1983-1985 [6]. Similarly, and in
contrast to recipients of combined grafts, male patients
with diabetic nephropathy were selected preferentially
for kidney transplantation alone, as shown by the sex
ratio of 66% males versus 34% females. These sex
imbalances between the two groups should, in any
event, have little influence on patient and graft survival.
The results of kidney transplantation have long been
known to be identical or very similar [7] when compar-
ing males with females. The difference in age dis-
tribution (which is not statistically significant) would be
predicted to result in slightly better patient survival in
the younger recipients of combined grafts, whilst the
effect on kidney graft survival is likely to be small [8].
That no such differences were apparent might be due to
the relatively small number of patients included in the
present study. Also, the much improved patient survival
rates attained in recent years makes detection of small
differences very difficult.
As the early postoperative hazards following com-
bined kidney and pancreas grafting now appear to be
comparable to those of kidney grafting alone, and the
kidney graft survival is not adversely affected by pan-
creatic grafting, it seems justified to continue to perform
combined grafts, at least in surgical units with the
appropriate experience [9]. The outcome of pancreatic
function in patients undergoing combined grafting is
also encouraging, since only 20% of the patients with a
functioning kidney graft had lost their simultaneously
transplanted pancreas within the first year. Most of the
pancreatic graft losses were confined to the first three
months after transplantation, and the survival of a
pancreas graft alone after kidney graft failure seems to
be a rare event (one patient only in this series).
It is the intention of the EDTA Registry to obtain
follow-up information on the present cohort of patients
with combined kidney/pancreas grafts within 2-3 years,
in order to establish any possible beneficial long-term
effects of simultaneous pancreas grafting.
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